A murine model of angiotensin II (AngII) -induced AF was used to investigate whether inhibition of FXa with edoxaban has anti-arrhythmic and anti-fibrotic effects and can therefore oppose the development or progression of AF (Mollenhauer and Rudolph, first published here). The gene discussed is F10; the disease is atrial fibrillation.